ATF3 and breast cancer: The strong up-regulation of the Activating transcription factor 3 (ATF3) (16.8-fold) associated to EndoR stress and the abrogation of the apoptotic response after ATF3 silencing suggests this protein as a potential molecular target for γ-tocotrienol in breast cancer cells.